New Extramural Funding
Updated: September 13, 2018
Following is a list of the most recently announced cancer-focused extramural funding opportunities. Please refer to our Upcoming Funding page for additional funding opportunities.
National Institutes of Health
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) — Application Deadline: 9/19/18
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) — Application Deadline: 10/5/18
Integration of Individual Residential Histories into Cancer Research (R01) — Application Deadline: 10/5/18
Assay development and screening for discovery of chemical probes or therapeutic agents (R01) — Application Deadline: 10/5/18
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01) — Application Deadline: 10/5/18
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) — Application Deadline: 10/5/18
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) — Application Deadline: 10/5/18
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01) — Application Deadline: 10/5/18
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) — Application Deadline: 10/5/18
Biology of Lung, and Head and Neck Preneoplasias (R01 – Clinical Trial Not Allowed) — Application Deadline: 10/5/18
Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01-Clinical Trial Not Allowed) — Application Deadline: 10/5/18
Symptom Cluster Characterization in Chronic Conditions (R01) — Application Deadline: 10/5/18
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) — Application Deadline: 10/5/18
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03) — Application Deadline: 10/16/18
Integration of Individual Residential Histories into Cancer Research (R21) — Application Deadline: 10/16/18
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) — Application Deadline: 10/16/18
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) — Application Deadline: 10/16/18
Social Epigenomics Research Focused on Minority Health and Health Disparities (R21) — Application Deadline: 10/16/18
Biology of Lung, and Head and Neck Preneoplasias (R21 – Clinical Trial Not Allowed) — Application Deadline: 10/16/18
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) — Application Deadline: 10/16/18
Symptom Cluster Characterization in Chronic Conditions (R21) — Application Deadline: 10/16/18
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) — Application Deadline: 10/16/18
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 – Clinical Trial Not Allowed) — Application Deadline: 10/24/18
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 – Clinical Trial Not Allowed) — Application Deadline: 10/24/18
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 – Clinical Trial Optional) — Application Deadline: 10/24/18
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 – Clinical Trial Optional) — Application Deadline: 10/24/18
Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01 Clinical Trial Not Allowed) — Application Deadline: 10/29/18
Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed) — Application Deadline: 10/29/18
Limited Competition: Lasker Clinical Research Scholars Transition Award (R00) — Application Deadline: Rolling Dates
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) — Application Deadline: Rolling Dates
Congressionally Directed Medical Research Programs (CDMRP)
Peer Reviewed Cancer Research Program – Horizon Award — Application Deadline: 9/26/18
Lung Cancer Research Program: Career Development Award — Application Deadline: 9/26/18
Peer Reviewed Cancer Research Program: Impact Award — Application Deadline: 9/26/18
Peer Reviewed Cancer Research Program: Career Development Award — Application Deadline: 9/26/18
Peer Reviewed Cancer Research Program: Idea Award with Special Focus — Application Deadline: 9/26/18
Peer Reviewed Cancer Research Program: Translational Team Science Award — Application Deadline: 9/26/18
Breast Cancer Research Program -Breakthrough Award Levels 3 and 4 — Pre-Application: 9/14/18 Application Deadline:12/10/18
American Association for Cancer Research
AACR NextGen Grants for Transformative Cancer Research — LOI Deadline: 9/28/18
American Cancer Society
Research Scholar Grants — Application Deadline: 10/15/18
Postdoctoral Fellowships — Application Deadline: 10/15/18
Florida Department of Health
Bankhead-Coley Cancer Research Program — Application Deadline: 10/19/18
James & Esther King Biomedical Research Program — Application Deadline: 10/19/18
Live Like Bella Pediatric Cancer Research Initiative — Application Deadline: 10/19/18
Leukemia & Lymphoma Society
Career Development Program — Abstract Deadline: 9/15/18
Translational Research Program — Application Deadline: 10/31/18
Conquer Cancer – The ASCO Foundation
Young Investigator Award — Application Deadline: 9/25/18
Career Development Award — Application Deadline: 9/25/18
National Foundation for Cancer Research
2019 Szent-Györgyi Prize — Application Deadline: 9/30/18
Cancer Research Institute
CRI Irvington Postdoctoral Fellowship Program — Application Deadline: 10/1/18